Related Experiment Videos

Complement-derived anaphylatoxins in human donor corneas treated with excimer laser

B P Gardner1, U Pleyer, B J Mondino

  • 1Department of Ophthalmology, UCLA School of Medicine, USA.

Ophthalmic Surgery and Lasers
|November 1, 1995
PubMed
Abstract

Insights

Excimer laser photorefractive keratectomy (PRK) did not significantly increase complement anaphylatoxins in human corneas. This suggests the laser treatment, at this dose, does not trigger a significant inflammatory complement response post-surgery.

Area of Science:

  • Ophthalmology
  • Immunology
  • Laser Surgery

Background:

  • Post-photorefractive keratectomy (PRK) inflammation may cause corneal haze and refractive error regression.
  • Complement-derived anaphylatoxins are potent inflammatory mediators implicated in wound healing.

Purpose of the Study:

  • To investigate the role of complement activation in excimer laser PRK.
  • To determine if specific complement anaphylatoxins (C3a, C4a, C5a) are elevated after PRK treatment.

Main Methods:

  • Human donor corneas underwent a 6-diopter excimer laser PRK treatment.
  • Control corneas were used for comparison.
  • Corneal eluates were analyzed for C3a, C4a, and C5a levels using radioimmunoassay after incubation and elution.

Main Results:

  • No significant increase in C3a, C4a, or C5a levels was observed in PRK-treated corneas compared to controls.
  • Statistical analysis showed P > .05, indicating no significant difference.

Conclusions:

  • The findings suggest that excimer laser treatment at the specified dose does not induce significant complement activation in the cornea.
  • This implies that complement anaphylatoxins may not play a major role in the inflammatory response following this type of PRK procedure.

Related Concept Videos